中新网4月19日电 – 市场监管总局近日在其官方网站上披露,2023年度我国市场监管部门在维护消费者权益、净化市场环境方面取得了显著成效。针对医疗、药品、医疗器械及保健食品等与民生息息相关的领域,市场监管部门加大了对“神医”“神药”虚假违法广告的查处力度,共查处相关案件9572件,涉及罚没金额1.25亿元。

这些违法广告往往利用误导性的宣传手段,夸大产品功效,误导消费者,对公众健康构成潜在威胁。市场监管总局的此次行动,旨在打击此类不法行为,保护消费者的知情权和健康权益,维护市场公平竞争秩序。

据市场监管总局介绍,此次打击行动是针对民生热点问题的精准施策,旨在消除广告市场的不良风气,增强公众对广告信息的信任度。未来,市场监管部门将继续强化监管,提高违法成本,以期形成对违法广告的强大震慑力。

市场监管总局表示,将持续关注民生领域广告的合法合规性,鼓励社会公众积极参与监督,共同营造诚实守信的市场环境,为人民群众的健康安全提供有力保障。同时,也提醒广大消费者在购买相关产品时,务必保持理性,审慎判断广告信息,以避免受到虚假宣传的影响。

英语如下:

**News Title:** “China’s Market Regulator Cracks Down on ‘Miracle Doctors’ and ‘Miracle Drugs’ Ads, Investigating 9,572 Illicit Cases and Imposing Fines of 1.25 Billion in 2023”

**Keywords:** Market regulation, Miracle doctors, Miracle drugs, Advertising violations

**News Content:**

**BEIJING, April 19 (Xinhua) -** China’s State Administration for Market Regulation (SAMR) recently announced on its official website that it has made significant progress in 2023 in protecting consumer rights and purifying the market environment. Focusing on areas crucial to people’s livelihood, such as healthcare, pharmaceuticals, medical devices, and health food, the regulator intensified its efforts to combat false and illegal advertisements promoting “miracle doctors” and “miracle drugs,” investigating 9,572 cases and imposing fines and forfeitures totaling 1.25 billion yuan.

These illicit advertisements often employ misleading tactics to exaggerate product efficacy, misleading consumers and posing potential threats to public health. The SAMR’s initiative aims to combat such unlawful practices, safeguard consumers’ right to know and protect their health rights, as well as maintain fair market competition.

According to the SAMR, this targeted crackdown addresses pressing issues related to public welfare, striving to eradicate unhealthy trends in the advertising market and enhance public trust in advertising information. The agency vowed to reinforce supervision and increase the cost of violating the law, thereby deterring future illicit advertising activities.

The regulator emphasized its commitment to monitoring the legality and compliance of advertisements in sectors concerning people’s livelihoods and encouraged public participation in supervision. Together, they aim to foster an honest and trustworthy market environment, providing robust safeguards for the health and safety of the people. The SAMR also reminded consumers to remain rational when purchasing related products, carefully evaluating advertising claims to avoid falling prey to false promotions.

【来源】http://www.chinanews.com/cj/2024/04-19/10201968.shtml

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注